Free Trial
→ Elon’s 2025 Silver Crisis (What It Means for You) (From GoldenCrest Metals) (Ad)
NASDAQ:ONCO

Onconetix 11/17/2023 Earnings Report

Onconetix logo
$0.07 +0.00 (+1.92%)
As of 03:23 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
ProfileEarnings History

Onconetix EPS Results

Actual EPS
-$11.20
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Onconetix Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Onconetix Announcement Details

Quarter
Date
11/17/2023
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Onconetix's next earnings date is estimated for Monday, June 2, 2025, based on past reporting schedules.

Conference Call Resources

Onconetix Earnings Headlines

Onconetix faces potential Nasdaq delisting over filing delays
May 24, 2025 | investing.com
Onconetix receives additional delisting notice from Nasdaq
May 23, 2025 | finance.yahoo.com
While others chase AI stocks, smart traders do this
Since the pandemic, the average mortgage payment has jumped from $1,427 to $2,047. That's an extra $600 every single month just vanishing from people's pockets. Meanwhile, credit card debt is hitting record highs, and savings accounts are at their lowest since 2008. Most folks are left with two options… Get a second job... or work overtime on weekends. But what if there was a third option? I just uncovered a shocking anomaly in the options market that could change everything... One that lets you target extra cash on days when most people make nothing - weekends. Think what that could mean for your monthly budget...
May 29, 2025 | WealthPress (Ad)
Onconetix, Inc. Announces Receipt of Additional Notice from Nasdaq
May 22, 2025 | globenewswire.com
Onco-Innovations Uplists to Cboe Canada
May 22, 2025 | businesswire.com
Onconetix, Inc. Announces Receipt of Additional Notice from Nasdaq
April 30, 2025 | globenewswire.com
See More Onconetix Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Onconetix? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Onconetix and other key companies, straight to your email.

About Onconetix

Onconetix (NASDAQ:ONCO), a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology. It offers Entadfi, an FDA-approved, once daily pill that combines finasteride and tadalafil for the treatment of benign prostatic hyperplasia; and Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer. The company was formerly known as Blue Water Biotech, Inc. and changed its name to Onconetix, Inc. in December 2023. Onconetix, Inc. was incorporated in 2018 and is headquartered in Cincinnati, Ohio.

View Onconetix Profile

More Earnings Resources from MarketBeat

Earnings Tools
Earnings By Country
Latest Articles